4//SEC Filing
Koenig Sheldon L. 4
Accession 0001628280-23-007969
CIK 0001434868other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 9:21 AM ET
Size
7.0 KB
Accession
0001628280-23-007969
Insider Transaction Report
Form 4
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2023-03-14+105,000→ 299,815 total - Award
Stock Option (right to buy)
2023-03-14+445,000→ 445,000 totalExercise: $4.02Exp: 2033-03-14→ Common Stock (445,000 underlying)
Footnotes (2)
- [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service.
- [F2]Such options will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001766524
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 9:21 AM ET
- Size
- 7.0 KB